US › Healthcare

STERIS plc (STE)

US · Healthcare · Medical Devices

$232.85+0.09%

Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue

$1.59B

Revenue YoY

+7.3%

Net profit

$220.3M

Profit YoY

+51.2%

EPS

$2.83

EPS estimate

$2.85

Net margin

13.9%

EPS came in at 2.83 against a street estimate of 2.85 — a miss of 0.7%.

Key statistics

Market cap

$22.26B

P/E

28.8

Forward P/E

20.5

P/B

3.10

Book value

$73.45

EPS (TTM)

$7.93

Dividend yield

1.06%

52-week high

$267.96

52-week low

$194.56

50-day MA

$213.35

200-day MA

$234.54

Beta

0.92

Analyst view

Analysts rate STERIS plc a buy (5 buy, 5 hold, 0 sell out of 10) with an average price target of $255.38.

Shareholding

Insiders

0.31%

Institutions

99.94%

Largest institutional holders

Fund	Stake
BlackRock Inc	9.26%
Vanguard Capital Management, LLC	6.53%
State Street Corp	5.12%
Vanguard Portfolio Management, LLC	5.08%
Morgan Stanley - Brokerage Accounts	4.51%
Massachusetts Financial Services Company	4.12%
Wellington Management Company LLP	2.95%
Orbis Allan Gray Ltd	2.66%

Recent filings & reports

Document	Date
Proxy statement · Q3 2026	2026-06-11
Annual report FY2026	2026-05-29
Results announced · Q2 2026	2026-05-11
Board / officer change · Q2 2026	2026-05-07
Board / officer change · Q1 2026	2026-04-06
Quarterly report · Q4 2025	2026-02-06
Results announced · Q1 2026	2026-02-04
Quarterly report · Q3 2025	2025-11-06

Readable in the app.

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for STERIS plc — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Novo Nordisk A/S Amgen Inc Abbott Laboratories Gilead Sciences Inc

Data updated 2026-08-05.